Lunai Bioworks Inc.
LNAI
$0.56
$0.34162.77%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.53% | -6.09% | -101.31% | 30.12% | -206.05% |
| Total Depreciation and Amortization | -6.83% | 8.82% | 5.91% | 7.41% | 7.88% |
| Total Amortization of Deferred Charges | -76.43% | -93.86% | -94.49% | -80.99% | -55.99% |
| Total Other Non-Cash Items | 9.67% | 15.88% | 141.55% | -35.73% | 283.13% |
| Change in Net Operating Assets | -61.10% | -52.55% | -33.50% | 31.20% | 585.80% |
| Cash from Operations | 40.57% | 29.41% | 28.23% | 21.65% | 16.27% |
| Capital Expenditure | 95.85% | -- | -- | 55.47% | 39.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 124.56% | 122.60% | 60.18% | -21.89% | 83.05% |
| Cash from Investing | 130.00% | 122.10% | 60.32% | -25.14% | 87.07% |
| Total Debt Issued | -15.31% | 13.19% | -13.27% | 16.13% | 107.09% |
| Total Debt Repaid | 6.95% | -12.36% | -11.62% | 0.38% | 18.72% |
| Issuance of Common Stock | 11.07% | -4.60% | 60.87% | 10.38% | -46.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -37.75% | -22.90% | -20.30% | 14.76% | 10.97% |
| Foreign Exchange rate Adjustments | -285.06% | -203.09% | -325.91% | -167.18% | 505.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 165.19% | 233.44% | 92.27% | 123.16% | 101.75% |